Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease
- 15 March 2003
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 111 (6), 907-913
- https://doi.org/10.1172/jci200317429
Abstract
Neuronal nicotinic AChRs (nAChRs) are implicated in the pathogenesis of diverse neurological disorders and in the regulation of small-cell lung carcinoma growth. Twelve subunits have been identified in vertebrates, and mutations of one are recognized in a rare form of human epilepsy. Mice with genetically manipulated neuronal nAChR subunits exhibit behavioral or autonomic phenotypes. Here, we report the first model of an acquired neuronal nAChR disorder and evidence for its pertinence to paraneoplastic neurological autoimmunity. Rabbits immunized once with recombinant α3 subunit (residues 1–205) develop profound gastrointestinal hypomotility, dilated pupils with impaired light response, and grossly distended bladders. As in patients with idiopathic and paraneoplastic autoimmune autonomic neuropathy, the severity parallels serum levels of ganglionic nAChR autoantibody. Failure of neurotransmission through abdominal sympathetic ganglia, with retention of neuronal viability, confirms that the disorder is a postsynaptic channelopathy. In addition, we found ganglionic nAChR protein in small-cell carcinoma lines, identifying this cancer as a potential initiator of ganglionic nAChR autoimmunity. The data support our hypothesis that immune responses driven by distinct neuronal nAChR subtypes expressed in small-cell carcinomas account for several lung cancer–related paraneoplastic disorders affecting cholinergic systems, including autoimmune autonomic neuropathy, seizures, dementia, and movement disorders.This publication has 28 references indexed in Scilit:
- Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptorClinical Autonomic Research, 2002
- Multiple Sclerosis: Deeper Understanding of Its Pathogenesis Reveals New Targets for TherapyAnnual Review of Neuroscience, 2002
- Functional Properties of Human Nicotinic Achrs Expressed by Imr-32 Neuroblastoma Cells Resemble Those of α3β4 Achrs Expressed in Permanently Transfected Hek CellsThe Journal of general physiology, 2001
- Paraneoplastic Neurologic Disease Antigens: RNA-Binding Proteins and Signaling Proteins in Neuronal DegenerationAnnual Review of Neuroscience, 2001
- The unusual nature of epibatidine responses at the α4β2 nicotinic acetylcholine receptorNeuropharmacology, 2000
- Nicotinic Acetylcholine Receptors of Muscle and Neuronal (α7) Types Coexpressed in a Small Cell Lung CarcinomaJournal of Neurochemistry, 1997
- Myasthenia GravisThe New England Journal of Medicine, 1994
- Serotonin release and cell proliferation are under the control of α‐bungarotoxin‐sensitive nicotinic receptors in small‐cell lung carcinoma cell linesFEBS Letters, 1994
- Antisera against an acetylcholine receptor α3 fusion protein bind to ganglionic but not to brain nicotinic acetylcholine receptorsFEBS Letters, 1989
- Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs.The Journal of Experimental Medicine, 1975